Astellas Pharma Inc. (ALPMY)
OTC: ALPMY
· Real-Time Price · USD
11.33
0.15 (1.34%)
At close: Aug 15, 2025, 3:58 PM
11.30
-0.26%
After-hours: Aug 15, 2025, 03:58 PM EDT
Astellas Pharma Cash Flow Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 50.75B | -57.43B | 54.75B | 17.38B | 12.9B | 58M | 33.95B | 107.03B | 98.72B | 136.43B | 148.91B | 118.21B | 124.08B | 120.17B | 119.36B | 100.86B | 120.59B | 138.31B | 139.72B | 187.31B |
Depreciation & Amortization | 199.13B | 200.09B | 195.91B | 184.86B | 157.84B | 132.21B | 108.23B | 92.11B | 105.74B | 103.8B | 102.33B | 98.41B | 79.68B | 40.04B | 36.67B | 35.67B | 35.53B | 72.19B | 71.19B | 67.38B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 37.55B | 55.83B | 70.38B | 76.88B | 34.82B | 80.99B | 94.28B | 59.53B | 98.19B | 29.77B | -27.51B | 8.08B | -16.64B | -7.43B | 64.48B | 52.89B | 47.39B | 43.86B | 26.47B | -15.33B |
Other Non-Cash Items | 85.12B | 214.3B | 82.82B | 88.48B | 155.54B | 74.69B | 64.04B | 122.43B | 206.56B | 228.93B | 281.58B | 237.88B | 218.49B | 200.49B | 155.85B | 148.16B | 45.81B | 10.65B | -6.11B | 10.19B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -140.49B | -95.71B | -35.18B | -17.16B | -51.7B | 17.87B | 38.92B | 23.98B | 73.98B | -16.59B | -48.16B | 8.73B | -10.68B | 16.87B | 70.4B | 71.88B | 74.86B | 55.7B | 30.5B | -28.69B |
Operating Cash Flow | 194.51B | 167.99B | 205.04B | 180.31B | 181.32B | 224.84B | 245.14B | 296.82B | 332.32B | 263.01B | 259.36B | 267.06B | 258.16B | 291.59B | 332.04B | 325.94B | 307.33B | 276.85B | 235.3B | 236.19B |
Capital Expenditures | -37B | -47.23B | -64.79B | -80.13B | -82.5B | -90.69B | -96.16B | -86.64B | -88.54B | -77.69B | -68.26B | -74.8B | -76.45B | -77.75B | -75.41B | -53.82B | -41.49B | -33.1B | -38.66B | -41.51B |
Cash Acquisitions | n/a | -190M | -24.92B | -784.97B | -784.97B | -784.78B | -760.05B | n/a | n/a | 25M | 164M | 233M | -229M | -3M | -13.34B | -13.45B | -14.65B | -322.75B | -317.39B | -317.29B |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 12.62B | 12.69B | 12.69B | 12.69B | 64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -52.42B | -67.4B | -36.36B | -18.81B | 9.19B | 7.74B | 2.2B | -9.39B | -13.2B | -1.25B | 25.32B | 13.22B | 13.55B | 12.38B | -13.97B | -10.6B | -28.83B | -27.29B | -25.47B | -45.33B |
Investing Cash Flow | -89.42B | -111.19B | -122.44B | -880.28B | -854.65B | -855.11B | -841.32B | -83.34B | -89.06B | -78.86B | -42.77B | -61.34B | -63.13B | -62.78B | -100.13B | -75.27B | -82.38B | -383.14B | -381.52B | -404.14B |
Debt Repayment | -55.6B | 11.06B | 9.4B | 537.23B | 771.23B | 678.12B | 745.35B | 204B | -15B | 15B | -35B | -45B | -60B | -85B | -104B | -96B | -126B | -81B | -62B | -30B |
Common Stock Repurchased | -6.96B | -6.96B | -6.96B | -6.96B | -10.73B | -60.73B | -60.73B | -60.73B | -60.56B | -60.56B | -60.55B | -60.56B | -50.72B | -9B | -9B | -9B | -9.16B | -15.72B | -52.59B | -53.78B |
Dividend Paid | -128.99B | -128.99B | -125.51B | -125.51B | -116.65B | -116.65B | -108.58B | -108.58B | -100.36B | -100.36B | -92B | -92B | -85.24B | -85.24B | -77.92B | -77.92B | -76.16B | -76.16B | -74.86B | -74.86B |
Other Financial Acitivies | -76.77B | -21.69B | -6.24B | 25.38B | -29.79B | -22.1B | -20.07B | -18.66B | -19.71B | -20.24B | -20.24B | -20.61B | -20.34B | -20.17B | -18.76B | -18.32B | -18.16B | 307.83B | 306.73B | 307.07B |
Financial Cash Flow | -261.37B | -139.63B | -122.36B | 437.1B | 614.06B | 478.63B | 555.96B | 16.02B | -195.62B | -166.15B | -207.79B | -218.17B | -216.3B | -199.41B | -209.68B | -201.23B | -229.48B | 134.95B | 117.28B | 148.43B |
Net Cash Flow | 188.37B | 261.57B | 1.69B | 77.13B | -41.15B | -127.84B | -27.08B | 248.47B | 60.85B | 31.6B | 42.78B | 11.09B | -10.14B | 43.7B | 31.56B | 61.99B | 7.74B | 28.91B | -24.63B | -19.49B |
Free Cash Flow | 157.51B | 120.76B | 140.25B | 100.18B | 98.83B | 134.15B | 148.98B | 210.18B | 243.78B | 185.32B | 191.1B | 192.27B | 181.71B | 213.84B | 256.63B | 272.13B | 265.83B | 243.75B | 196.64B | 194.68B |